210 related articles for article (PubMed ID: 15529489)
1. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of osteoporosis.
Lloyd M
Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
[No Abstract] [Full Text] [Related]
3. An approach to postmenopausal osteoporosis treatment: a case study review.
Kessenich C
J Am Acad Nurse Pract; 2003 Dec; 15(12):539-45. PubMed ID: 14983569
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
5. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Compston JE
Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
[No Abstract] [Full Text] [Related]
6. Osteoporosis management in the new millennium.
Wei GS; Jackson JL; Hatzigeorgiou C; Tofferi JK
Prim Care; 2003 Dec; 30(4):711-41, vi-vii. PubMed ID: 15024893
[TBL] [Abstract][Full Text] [Related]
7. Summaries for patients. Drug therapy for osteoporosis.
Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
[No Abstract] [Full Text] [Related]
8. Gastroenterologists and choosing the right bisphosphonate.
Leder BZ; Kronenberg HM
Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
[No Abstract] [Full Text] [Related]
9. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
10. Oral antiresorptive therapy.
Pande I; Hosking DJ
Curr Osteoporos Rep; 2004 Dec; 2(4):116-22. PubMed ID: 16036092
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis: which current treatments reduce fracture risk?
Baran DT
Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
[TBL] [Abstract][Full Text] [Related]
12. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Trémollières F
Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
[No Abstract] [Full Text] [Related]
13. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
14. Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML; Leonard M; Licata AA
Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
[TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis: diagnosis, prevention and treatment].
Baranauskaite A; Savickiene A
Medicina (Kaunas); 2002; 38(2):234-9; quiz 240. PubMed ID: 12474746
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for osteoporosis.
Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
[TBL] [Abstract][Full Text] [Related]
17. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
18. Bisphosphonates.
Diez-Perez A
Maturitas; 2002 Aug; 43 Suppl 1():S19-26. PubMed ID: 12361885
[No Abstract] [Full Text] [Related]
19. [Effect of anti-osteoporosis agents on the incidence of vertebral fractures].
Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1941-5. PubMed ID: 11048556
[TBL] [Abstract][Full Text] [Related]
20. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 2001 Feb; 27(1):197-214. PubMed ID: 11285996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
